{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:55:53Z","timestamp":1790985353693,"version":"4.1.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-40095-4","type":"journal-article","created":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T06:28:38Z","timestamp":1772778518000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Targeting AT1 receptors with telmisartan protects SH-SY5Y cells from 6-OHDA induced Parkinsonian neurotoxicity"],"prefix":"10.1038","volume":"16","author":[{"given":"Omer Lutfi","family":"Gundogdu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feyza","family":"Burul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif Tugce","family":"Akyol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ufuk","family":"Okkay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma","family":"Yesilyurt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatih Burak","family":"Yildiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8836-9547","authenticated-orcid":false,"given":"Irmak Ferah","family":"Okkay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Ozkaraca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet","family":"Hacimuftuoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,6]]},"reference":[{"key":"40095_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1749-6632.2003.tb07458.x","volume":"991","author":"S Fahn","year":"2003","unstructured":"Fahn, S. Description of parkinson\u2019s disease as a clinical syndrome. Ann. N. Y. Acad. Sci. 991, 1\u201314. https:\/\/doi.org\/10.1111\/j.1749-6632.2003.tb07458.x (2003). 2003\/07\/09.","journal-title":"Ann. N Y Acad. Sci."},{"key":"40095_CR2","doi-asserted-by":"publisher","first-page":"9832839","DOI":"10.1155\/2016\/9832839","volume":"2016","author":"F Magrinelli","year":"2016","unstructured":"Magrinelli, F. et al. Pathophysiology of motor dysfunction in parkinson\u2019s disease as the rationale for drug treatment and rehabilitation. Parkinsons Dis. 2016, 9832839. https:\/\/doi.org\/10.1155\/2016\/9832839 (2016).","journal-title":"Parkinsons Dis."},{"key":"40095_CR3","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.nbd.2011.09.015","volume":"45","author":"F Mela","year":"2012","unstructured":"Mela, F. et al. In vivo evidence for a differential contribution of striatal and nigral D1 and D2 receptors to L-DOPA induced dyskinesia and the accompanying surge of nigral amino acid levels. Neurobiol. Dis. 45, 573\u2013582. https:\/\/doi.org\/10.1016\/j.nbd.2011.09.015 (2012).","journal-title":"Neurobiol. Dis."},{"key":"40095_CR4","doi-asserted-by":"publisher","unstructured":"Phani, S., Loike, J. D. & Przedborski, S. Neurodegeneration and inflammation in Parkinson\u2019s disease. Parkinsonism Relat. Disord. 18(Suppl 1), S207\u2013209. https:\/\/doi.org\/10.1016\/S1353-8020(11)70064-5 (2012).","DOI":"10.1016\/S1353-8020(11)70064-5"},{"key":"40095_CR5","doi-asserted-by":"publisher","first-page":"5256","DOI":"10.1523\/JNEUROSCI.0984-06.2006","volume":"26","author":"PM Keeney","year":"2006","unstructured":"Keeney, P. M. et al. Parkinson\u2019s disease brain mitochondrial complex I has oxidatively damaged subunits and is functionally impaired and misassembled. J. Neurosci. 26, 5256\u20135264. https:\/\/doi.org\/10.1523\/JNEUROSCI.0984-06.2006 (2006).","journal-title":"J. Neurosci."},{"key":"40095_CR6","doi-asserted-by":"publisher","unstructured":"Tatton, W. G. et al. Apoptosis in Parkinson\u2019s disease: signals for neuronal degradation. Ann. Neurol. 53(Suppl 3), S61\u2013S70; discussion S70\u201362 (2003). https:\/\/doi.org\/10.1002\/ana.10489","DOI":"10.1002\/ana.10489"},{"key":"40095_CR7","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.neuint.2012.12.016","volume":"62","author":"JM Taylor","year":"2013","unstructured":"Taylor, J. M., Main, B. S. & Crack, P. J. Neuroinflammation and oxidative stress: co-conspirators in the pathology of parkinson\u2019s disease. Neurochem Int. 62, 803\u2013819. https:\/\/doi.org\/10.1016\/j.neuint.2012.12.016 (2013).","journal-title":"Neurochem Int."},{"key":"40095_CR8","doi-asserted-by":"publisher","first-page":"344","DOI":"10.3389\/fnins.2018.00344","volume":"12","author":"L Rodriguez","year":"2018","unstructured":"Rodriguez, L., Marano, M. M. & Tandon, A. Import and export of misfolded alpha-Synuclein. Front. Neurosci. 12, 344. https:\/\/doi.org\/10.3389\/fnins.2018.00344 (2018).","journal-title":"Front. Neurosci."},{"key":"40095_CR9","first-page":"226","volume":"1","author":"JL Labandeira-Garcia","year":"2012","unstructured":"Labandeira-Garcia, J. L. et al. Brain angiotensin and dopaminergic degeneration: relevance to parkinson\u2019s disease. Am. J. Neurodegener Dis. 1, 226\u2013244 (2012).","journal-title":"Am. J. Neurodegener Dis."},{"key":"40095_CR10","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3389\/fnagi.2017.00129","volume":"9","author":"JL Labandeira-Garcia","year":"2017","unstructured":"Labandeira-Garcia, J. L. et al. Brain Renin-Angiotensin system and microglial polarization: implications for aging and neurodegeneration. Front. Aging Neurosci. 9, 129. https:\/\/doi.org\/10.3389\/fnagi.2017.00129 (2017).","journal-title":"Front. Aging Neurosci."},{"issue":"2","key":"40095_CR11","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1002\/glia.22765","volume":"63","author":"AI Rodriguez-Perez","year":"2015","unstructured":"Rodriguez-Perez, A. I. et al. Interaction between NADPH-oxidase and Rho-kinase in angiotensin II-induced microglial activation. Glia 63(2), 466\u2013482. https:\/\/doi.org\/10.1002\/glia.22765 (2015).","journal-title":"Glia"},{"key":"40095_CR12","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1007\/s12035-015-9177-3","volume":"53","author":"Q Gao","year":"2016","unstructured":"Gao, Q. et al. Activation of autophagy contributes to the angiotensin II-Triggered apoptosis in a dopaminergic neuronal cell line. Mol. Neurobiol. 53, 2911\u20132919. https:\/\/doi.org\/10.1007\/s12035-015-9177-3 (2016).","journal-title":"Mol. Neurobiol."},{"key":"40095_CR13","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1002\/glia.22670","volume":"62","author":"L Morato","year":"2014","unstructured":"Morato, L. et al. Mitochondrial dysfunction in central nervous system white matter disorders. Glia 62, 1878\u20131894. https:\/\/doi.org\/10.1002\/glia.22670 (2014).","journal-title":"Glia"},{"key":"40095_CR14","doi-asserted-by":"publisher","first-page":"8940","DOI":"10.1523\/JNEUROSCI.0026-12.2012","volume":"32","author":"CN Hall","year":"2012","unstructured":"Hall, C. N. et al. Oxidative phosphorylation, not glycolysis, powers presynaptic and postsynaptic mechanisms underlying brain information processing. J. Neurosci. 32, 8940\u20138951. https:\/\/doi.org\/10.1523\/JNEUROSCI.0026-12.2012 (2012).","journal-title":"J. Neurosci."},{"key":"40095_CR15","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1111\/j.1471-4159.2009.05999.x","volume":"109","author":"B Joglar","year":"2009","unstructured":"Joglar, B. et al. The inflammatory response in the MPTP model of parkinson\u2019s disease is mediated by brain angiotensin: relevance to progression of the disease. J. Neurochem. 109, 656\u2013669. https:\/\/doi.org\/10.1111\/j.1471-4159.2009.05999.x (2009).","journal-title":"J. Neurochem"},{"key":"40095_CR16","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.neurobiolaging.2006.02.018","volume":"28","author":"P Rey","year":"2007","unstructured":"Rey, P. et al. Angiotensin type-1-receptor antagonists reduce 6-hydroxydopamine toxicity for dopaminergic neurons. Neurobiol. Aging. 28, 555\u2013567. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2006.02.018 (2007).","journal-title":"Neurobiol. Aging"},{"key":"40095_CR17","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.nbd.2008.03.003","volume":"31","author":"J Rodriguez-Pallares","year":"2008","unstructured":"Rodriguez-Pallares, J. et al. Brain angiotensin enhances dopaminergic cell death via microglial activation and NADPH-derived ROS. Neurobiol. Dis. 31, 58\u201373. https:\/\/doi.org\/10.1016\/j.nbd.2008.03.003 (2008).","journal-title":"Neurobiol. Dis."},{"key":"40095_CR18","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.neuropharm.2013.05.025","volume":"73","author":"S Sathiya","year":"2013","unstructured":"Sathiya, S. et al. Telmisartan attenuates MPTP induced dopaminergic degeneration and motor dysfunction through regulation of alpha-synuclein and neurotrophic factors (BDNF and GDNF) expression in C57BL\/6J mice. Neuropharmacology 73, 98\u2013110. https:\/\/doi.org\/10.1016\/j.neuropharm.2013.05.025 (2013).","journal-title":"Neuropharmacology"},{"key":"40095_CR19","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s12640-018-9921-3","volume":"34","author":"S Sekar","year":"2018","unstructured":"Sekar, S. et al. Telmisartan ameliorates astroglial and dopaminergic functions in a mouse model of chronic parkinsonism. Neurotox. Res. 34, 597\u2013612. https:\/\/doi.org\/10.1007\/s12640-018-9921-3 (2018).","journal-title":"Neurotox. Res."},{"key":"40095_CR20","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/978-1-0716-1437-2_2","volume":"2311","author":"J Kovalevich","year":"2021","unstructured":"Kovalevich, J., Santerre, M. & Langford, D. Considerations for the use of SH-SY5Y neuroblastoma cells in neurobiology. Methods Mol. Biol. 2311, 9\u201323. https:\/\/doi.org\/10.1007\/978-1-0716-1437-2_2 (2021).","journal-title":"Methods Mol. Biol."},{"key":"40095_CR21","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.26355\/eurrev_202002_20211","volume":"24","author":"SM Zhi","year":"2020","unstructured":"Zhi, S. M. et al. Melatonin reduces OGD\/R-induced neuron injury by regulating redox\/inflammation\/apoptosis signaling. Eur. Rev. Med. Pharmacol. Sci. 24, 1524\u20131536. https:\/\/doi.org\/10.26355\/eurrev_202002_20211 (2020).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"40095_CR22","doi-asserted-by":"publisher","first-page":"7711","DOI":"10.1007\/s11033-021-06779-y","volume":"48","author":"I Ferah Okkay","year":"2021","unstructured":"Ferah Okkay, I. et al. Neuroprotective effect of Bromelain in 6-hydroxydopamine induced in vitro model of parkinson\u2019s disease. Mol. Biol. Rep. 48, 7711\u20137717. https:\/\/doi.org\/10.1007\/s11033-021-06779-y (2021).","journal-title":"Mol. Biol. Rep."},{"key":"40095_CR23","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/s41598-025-30026-0","volume":"16","author":"O Altunlu","year":"2025","unstructured":"Altunlu, O. et al. Cilazapril and Benazepril mitigate neurodegeneration and alpha-synuclein accumulation in a cellular model of parkinson\u2019s disease. Sci. Rep. 16, 480. https:\/\/doi.org\/10.1038\/s41598-025-30026-0 (2025).","journal-title":"Sci. Rep."},{"key":"40095_CR24","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1080\/15569527.2021.1919137","volume":"40","author":"U Okkay","year":"2021","unstructured":"Okkay, U. et al. Effects of Achillea millefolium on cisplatin induced ocular toxicity: an experimental study. Cutan. Ocul Toxicol. 40, 214\u2013220. https:\/\/doi.org\/10.1080\/15569527.2021.1919137 (2021).","journal-title":"Cutan. Ocul Toxicol."},{"key":"40095_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/s11356-022-18626-z","author":"I Ferah Okkay","year":"2022","unstructured":"Ferah Okkay, I. et al. Centella Asiatica extract protects against cisplatin-induced hepatotoxicity via targeting oxidative stress, inflammation, and apoptosis. Environ. Sci. Pollut Res. Int. https:\/\/doi.org\/10.1007\/s11356-022-18626-z (2022).","journal-title":"Environ. Sci. Pollut Res. Int."},{"key":"40095_CR26","doi-asserted-by":"publisher","unstructured":"Ferah Okkay, I. et al. Bromelain protects against cisplatin-induced ocular toxicity through mitigating oxidative stress and inflammation. Drug Chem. Toxicol. https:\/\/doi.org\/10.1080\/01480545.2021.2011308 (2021).","DOI":"10.1080\/01480545.2021.2011308"},{"key":"40095_CR27","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1007\/s11033-024-09488-4","volume":"51","author":"O Birdal","year":"2024","unstructured":"Birdal, O. et al. Protective effects of arbutin against doxorubicin-induced cardiac damage. Mol. Biol. Rep. 51, 532. https:\/\/doi.org\/10.1007\/s11033-024-09488-4 (2024).","journal-title":"Mol. Biol. Rep."},{"key":"40095_CR28","doi-asserted-by":"publisher","first-page":"tfae075","DOI":"10.1093\/toxres\/tfae075","volume":"13","author":"IF Okkay","year":"2024","unstructured":"Okkay, I. F. et al. Arbutin abrogates cisplatin-induced hepatotoxicity via upregulating Nrf2\/HO-1 and suppressing genotoxicity, NF-kappaB\/iNOS\/TNF-alpha and caspase-3\/Bax\/Bcl2 signaling pathways in rats. Toxicol. Res. (Camb). 13, tfae075. https:\/\/doi.org\/10.1093\/toxres\/tfae075 (2024).","journal-title":"Toxicol. Res. (Camb)"},{"key":"40095_CR29","doi-asserted-by":"publisher","first-page":"e14028","DOI":"10.1111\/and.14028","volume":"53","author":"U Okkay","year":"2021","unstructured":"Okkay, U. et al. Achillea millefolium alleviates testicular damage in paclitaxel-intoxicated rats via Attenuation of testicular oxido-inflammatory stress and apoptotic responses. Andrologia 53, e14028. https:\/\/doi.org\/10.1111\/and.14028 (2021).","journal-title":"Andrologia"},{"key":"40095_CR30","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1111\/j.1742-4658.2012.08491.x","volume":"279","author":"F Blandini","year":"2012","unstructured":"Blandini, F. & Armentero, M. T. Animal models of parkinson\u2019s disease. FEBS J. 279, 1156\u20131166. https:\/\/doi.org\/10.1111\/j.1742-4658.2012.08491.x (2012).","journal-title":"FEBS J."},{"key":"40095_CR31","doi-asserted-by":"publisher","first-page":"376","DOI":"10.3969\/j.issn.1673-5374.2012.05.009","volume":"7","author":"X Chen","year":"2012","unstructured":"Chen, X., Guo, C. & Kong, J. Oxidative stress in neurodegenerative diseases. Neural Regen Res. 7, 376\u2013385. https:\/\/doi.org\/10.3969\/j.issn.1673-5374.2012.05.009 (2012). 2012\/02\/15.","journal-title":"Neural Regen Res."},{"key":"40095_CR32","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s11064-015-1661-7","volume":"41","author":"B Jarrott","year":"2016","unstructured":"Jarrott, B. & Williams, S. J. Chronic brain inflammation: the neurochemical basis for drugs to reduce inflammation. Neurochem Res. 41, 523\u2013533. https:\/\/doi.org\/10.1007\/s11064-015-1661-7 (2016).","journal-title":"Neurochem Res."},{"key":"40095_CR33","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.phrs.2017.06.017","volume":"125","author":"JM Saavedra","year":"2017","unstructured":"Saavedra, J. M. Beneficial effects of angiotensin II receptor blockers in brain disorders. Pharmacol. Res. 125, 91\u2013103. https:\/\/doi.org\/10.1016\/j.phrs.2017.06.017 (2017).","journal-title":"Pharmacol. Res."},{"key":"40095_CR34","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1038\/npp.2012.152","volume":"37","author":"S Villapol","year":"2012","unstructured":"Villapol, S. et al. Candesartan, an angiotensin II AT(1)-receptor blocker and PPAR-gamma agonist, reduces lesion volume and improves motor and memory function after traumatic brain injury in mice. Neuropsychopharmacology 37, 2817\u20132829. https:\/\/doi.org\/10.1038\/npp.2012.152 (2012).","journal-title":"Neuropsychopharmacology"},{"key":"40095_CR35","doi-asserted-by":"publisher","unstructured":"Rodriguez-Perez, A. I. et al. Angiotensin type 1 receptor antagonists protect against alpha-synuclein-induced neuroinflammation and dopaminergic neuron death. Neurotherapeutics 15, 1063\u20131081. https:\/\/doi.org\/10.1007\/s13311-018-0646-z. (2018).","DOI":"10.1007\/s13311-018-0646-z"},{"key":"40095_CR36","doi-asserted-by":"publisher","first-page":"3299","DOI":"10.1093\/brain\/awv172","volume":"138","author":"S Villapol","year":"2015","unstructured":"Villapol, S. et al. Neurorestoration after traumatic brain injury through angiotensin II receptor blockage. Brain 138, 3299\u20133315. https:\/\/doi.org\/10.1093\/brain\/awv172 (2015).","journal-title":"Brain"},{"key":"40095_CR37","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.neuropharm.2013.11.022","volume":"79","author":"J Wang","year":"2014","unstructured":"Wang, J. et al. Telmisartan ameliorates glutamate-induced neurotoxicity: roles of AT(1) receptor Blockade and PPARgamma activation. Neuropharmacology 79, 249\u2013261. https:\/\/doi.org\/10.1016\/j.neuropharm.2013.11.022 (2014).","journal-title":"Neuropharmacology"},{"key":"40095_CR38","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.freeradbiomed.2005.04.022","volume":"39","author":"S Guo","year":"2005","unstructured":"Guo, S., Bezard, E. & Zhao, B. Protective effect of green tea polyphenols on the SH-SY5Y cells against 6-OHDA induced apoptosis through ROS-NO pathway. Free Radic Biol. Med. 39, 682\u2013695. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2005.04.022 (2005).","journal-title":"Free Radic Biol. Med."},{"key":"40095_CR39","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.1016\/j.bbamcr.2016.09.012","volume":"1863","author":"M Redza-Dutordoir","year":"2016","unstructured":"Redza-Dutordoir, M. & Averill-Bates, D. A. Activation of apoptosis signalling pathways by reactive oxygen species. Biochim. Biophys. Acta. 1863, 2977\u20132992. https:\/\/doi.org\/10.1016\/j.bbamcr.2016.09.012 (2016).","journal-title":"Biochim. Biophys. Acta"},{"key":"40095_CR40","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.lfs.2018.12.029","volume":"218","author":"HA Elfawy","year":"2019","unstructured":"Elfawy, H. A. & Das, B. Crosstalk between mitochondrial dysfunction, oxidative stress, and age related neurodegenerative disease: etiologies and therapeutic strategies. Life Sci. 218, 165\u2013184. https:\/\/doi.org\/10.1016\/j.lfs.2018.12.029 (2019).","journal-title":"Life Sci."},{"key":"40095_CR41","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.3892\/ijmm.2018.3406","volume":"41","author":"JD Guo","year":"2018","unstructured":"Guo, J. D. et al. Damage to dopaminergic neurons by oxidative stress in parkinson\u2019s disease (Review). Int. J. Mol. Med. 41, 1817\u20131825. https:\/\/doi.org\/10.3892\/ijmm.2018.3406 (2018).","journal-title":"Int. J. Mol. Med."},{"key":"40095_CR42","doi-asserted-by":"publisher","first-page":"11","DOI":"10.5607\/en.2013.22.1.11","volume":"22","author":"O Hwang","year":"2013","unstructured":"Hwang, O. Role of oxidative stress in parkinson\u2019s disease. Exp. Neurobiol. 22, 11\u201317. https:\/\/doi.org\/10.5607\/en.2013.22.1.11 (2013).","journal-title":"Exp. Neurobiol."},{"key":"40095_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/antiox9080743","author":"DSA Simpson","year":"2020","unstructured":"Simpson, D. S. A. & Oliver, P. L. ROS generation in microglia: Understanding oxidative stress and inflammation in neurodegenerative disease. Antioxidants (Basel). https:\/\/doi.org\/10.3390\/antiox9080743 (2020).","journal-title":"Antioxid. (Basel)"},{"key":"40095_CR44","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/jcp.26865","volume":"234","author":"K Hassanzadeh","year":"2018","unstructured":"Hassanzadeh, K. & Rahimmi, A. Oxidative stress and neuroinflammation in the story of parkinson\u2019s disease: could targeting these pathways write a good ending? J. Cell. Physiol. 234, 23\u201332. https:\/\/doi.org\/10.1002\/jcp.26865 (2018).","journal-title":"J. Cell. Physiol."},{"key":"40095_CR45","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.neulet.2009.10.062","volume":"468","author":"P Scalzo","year":"2010","unstructured":"Scalzo, P. et al. Serum levels of interleukin-6 are elevated in patients with parkinson\u2019s disease and correlate with physical performance. Neurosci. Lett. 468, 56\u201358. https:\/\/doi.org\/10.1016\/j.neulet.2009.10.062 (2010).","journal-title":"Neurosci. Lett."},{"key":"40095_CR46","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.3892\/mmr.2014.2563","volume":"10","author":"J Yan","year":"2014","unstructured":"Yan, J. et al. Inflammatory response in parkinson\u2019s disease (Review). Mol. Med. Rep. 10, 2223\u20132233. https:\/\/doi.org\/10.3892\/mmr.2014.2563 (2014).","journal-title":"Mol. Med. Rep."},{"key":"40095_CR47","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.neurobiolaging.2006.04.011","volume":"28","author":"T Arimoto","year":"2007","unstructured":"Arimoto, T. et al. Interleukin-10 protects against inflammation-mediated degeneration of dopaminergic neurons in substantia Nigra. Neurobiol. Aging. 28, 894\u2013906. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2006.04.011 (2007).","journal-title":"Neurobiol. Aging"},{"key":"40095_CR48","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s10517-020-04723-x","volume":"168","author":"IV Miliukhina","year":"2020","unstructured":"Miliukhina, I. V. et al. Plasma cytokines profile in patients with parkinson\u2019s disease associated with mutations in GBA gene. Bull. Exp. Biol. Med. 168, 423\u2013426. https:\/\/doi.org\/10.1007\/s10517-020-04723-x (2020).","journal-title":"Bull. Exp. Biol. Med."},{"key":"40095_CR49","doi-asserted-by":"publisher","DOI":"10.1080\/01616412.2021.2024726","author":"H Piri","year":"2022","unstructured":"Piri, H. et al. Dopaminergic neuronal death in the substantia Nigra associates with change in serum levels of TNF-alpha and IL-1beta; evidence from early experimental model of parkinson\u2019s disease. Neurol. Res. https:\/\/doi.org\/10.1080\/01616412.2021.2024726 (2022).","journal-title":"Neurol. Res."},{"key":"40095_CR50","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.neuron.2013.09.004","volume":"79","author":"JT Bendor","year":"2013","unstructured":"Bendor, J. T., Logan, T. P. & Edwards, R. H. The function of alpha-synuclein. Neuron 79, 1044\u20131066. https:\/\/doi.org\/10.1016\/j.neuron.2013.09.004 (2013).","journal-title":"Neuron"},{"key":"40095_CR51","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/S0140-6736(04)17103-1","volume":"364","author":"MC Chartier-Harlin","year":"2004","unstructured":"Chartier-Harlin, M. C. et al. Alpha-synuclein locus duplication as a cause of Familial parkinson\u2019s disease. Lancet 364, 1167\u20131169. https:\/\/doi.org\/10.1016\/S0140-6736(04)17103-1 (2004).","journal-title":"Lancet"},{"key":"40095_CR52","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/bpa.12370","volume":"26","author":"A Atik","year":"2016","unstructured":"Atik, A., Stewart, T. & Zhang, J. Alpha-Synuclein as a biomarker for parkinson\u2019s disease. Brain Pathol. 26, 410\u2013418. https:\/\/doi.org\/10.1111\/bpa.12370 (2016).","journal-title":"Brain Pathol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-40095-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-40095-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-40095-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T18:01:28Z","timestamp":1776189688000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-40095-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,6]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["40095"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-40095-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,6]]},"assertion":[{"value":"30 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12298"}}